Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christoph M. Koch is active.

Publication


Featured researches published by Christoph M. Koch.


Nucleic Acids Research | 2010

Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene

Nele Gheldof; Emily Smith; Tomoko M. Tabuchi; Christoph M. Koch; Ian Dunham; John A. Stamatoyannopoulos; Job Dekker

Identification of regulatory elements and their target genes is complicated by the fact that regulatory elements can act over large genomic distances. Identification of long-range acting elements is particularly important in the case of disease genes as mutations in these elements can result in human disease. It is becoming increasingly clear that long-range control of gene expression is facilitated by chromatin looping interactions. These interactions can be detected by chromosome conformation capture (3C). Here, we employed 3C as a discovery tool for identification of long-range regulatory elements that control the cystic fibrosis transmembrane conductance regulator gene, CFTR. We identified four elements in a 460-kb region around the locus that loop specifically to the CFTR promoter exclusively in CFTR expressing cells. The elements are located 20 and 80 kb upstream; and 109 and 203 kb downstream of the CFTR promoter. These elements contain DNase I hypersensitive sites and histone modification patterns characteristic of enhancers. The elements also interact with each other and the latter two activate the CFTR promoter synergistically in reporter assays. Our results reveal novel long-range acting elements that control expression of CFTR and suggest that 3C-based approaches can be used for discovery of novel regulatory elements.


Genome Research | 2009

Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level

Alexander W. Bruce; Andrés J. López-Contreras; Paul Flicek; Thomas A. Down; Pawandeep Dhami; Shane C. Dillon; Christoph M. Koch; Cordelia Langford; Ian Dunham; Robert Andrews; David Vetrie

The molecular events that contribute to, and result from, the in vivo binding of transcription factors to their cognate DNA sequence motifs in mammalian genomes are poorly understood. We demonstrate that variations within the DNA sequence motifs that bind the transcriptional repressor REST (NRSF) encode in vivo DNA binding affinity hierarchies that contribute to regulatory function during lineage-specific and developmental programs in fundamental ways. First, canonical sequence motifs for REST facilitate strong REST binding and control functional classes of REST targets that are common to all cell types, whilst atypical motifs participate in weak interactions and control those targets, which are cell- or tissue-specific. Second, variations in REST binding relate directly to variations in expression and chromatin configurations of RESTs target genes. Third, REST clearance from its binding sites is also associated with variations in the RE1 motif. Finally, and most surprisingly, weak REST binding sites reside in DNA sequences that show the highest levels of constraint through evolution, thus facilitating their roles in maintaining tissue-specific functions. These relationships have never been reported in mammalian systems for any transcription factor.


PLOS ONE | 2010

Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution

Pawandeep Dhami; Peter Saffrey; Alexander W. Bruce; Shane C. Dillon; Kelly Chiang; Nicolas Bonhoure; Christoph M. Koch; Jackie Bye; Keith D. James; Nicola S. Foad; Peter Ellis; Nicholas A. Watkins; Willem H. Ouwehand; Cordelia Langford; Robert Andrews; Ian Dunham; David Vetrie

It has recently been shown that nucleosome distribution, histone modifications and RNA polymerase II (Pol II) occupancy show preferential association with exons (“exon-intron marking”), linking chromatin structure and function to co-transcriptional splicing in a variety of eukaryotes. Previous ChIP-sequencing studies suggested that these marking patterns reflect the nucleosomal landscape. By analyzing ChIP-chip datasets across the human genome in three cell types, we have found that this marking system is far more complex than previously observed. We show here that a range of histone modifications and Pol II are preferentially associated with exons. However, there is noticeable cell-type specificity in the degree of exon marking by histone modifications and, surprisingly, this is also reflected in some histone modifications patterns showing biases towards introns. Exon-intron marking is laid down in the absence of transcription on silent genes, with some marking biases changing or becoming reversed for genes expressed at different levels. Furthermore, the relationship of this marking system with splicing is not simple, with only some histone modifications reflecting exon usage/inclusion, while others mirror patterns of exon exclusion. By examining nucleosomal distributions in all three cell types, we demonstrate that these histone modification patterns cannot solely be accounted for by differences in nucleosome levels between exons and introns. In addition, because of inherent differences between ChIP-chip array and ChIP-sequencing approaches, these platforms report different nucleosome distribution patterns across the human genome. Our findings confound existing views and point to active cellular mechanisms which dynamically regulate histone modification levels and account for exon-intron marking. We believe that these histone modification patterns provide links between chromatin accessibility, Pol II movement and co-transcriptional splicing.


Stem Cells | 2008

Epigenetic Marking Prepares the Human HOXA Cluster for Activation During Differentiation of Pluripotent Cells

Stuart P. Atkinson; Christoph M. Koch; Gayle K. Clelland; Sarah Willcox; Joanna C. Fowler; Rebecca Stewart; Majlinda Lako; Ian Dunham; Lyle Armstrong

Activation of Hox gene clusters is an early event in embryonic development since individual members play important roles in patterning of the body axis. Their functions require precise control of spatiotemporal expression to provide positional information for the cells of the developing embryo, and the manner by which this control is achieved has generated considerable interest. The situation is different in pluripotent cells, where HOX genes are not expressed but are held in potentio as bivalent chromatin domains, which are resolved upon differentiation to permit HOX cluster activation. In this study we have used differentiation of the pluripotent embryonal carcinoma cell line NTera2SP12 and the human embryonic stem cell line H9 to examine epigenetic changes that accompany activation of the HOXA cluster and show that specific genomic loci are marked by lysine methylation of histone H3 (H3K4 tri‐ and dimethyl, H3K9 trimethyl) and acetylation of histone H4 even in the undifferentiated cells. The precise locations of such modified histones may be involved in controlling the colinear expression of genes from the cluster.


FEBS Journal | 2009

Novel genes in cell cycle control and lipid metabolism with dynamically regulated binding sites for sterol regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells detected by chromatin immunoprecipitation with microarray detection

Mehdi Motallebipour; Stefan Enroth; Tanel Punga; Adam Ameur; Christoph M. Koch; Ian Dunham; Jan Komorowski; Johan Ericsson; Claes Wadelius

Sterol regulatory element‐binding proteins 1 and 2 (SREBP‐1 and SREBP‐2) are important regulators of genes involved in cholesterol and fatty acid metabolism, but have also been implicated in the regulation of the cell cycle and have been associated with the pathogenesis of type 2 diabetes, atherosclerosis and obesity, among others. In this study, we aimed to characterize the binding sites of SREBP‐1 and RNA polymerase II through chromatin immunoprecipitation and microarray analysis in 1% of the human genome, as defined by the Encyclopaedia of DNA Elements consortium, in a hepatocellular carcinoma cell line (HepG2). Our data identified novel binding sites for SREBP‐1 in genes directly or indirectly involved in cholesterol metabolism, e.g. apolipoprotein C‐III (APOC3). The most interesting biological findings were the binding sites for SREBP‐1 in genes for host cell factor C1 (HCFC1), involved in cell cycle regulation, and for filamin A (FLNA). For RNA polymerase II, we found binding sites at classical promoters, but also in intergenic and intragenic regions. Furthermore, we found evidence of sterol‐regulated binding of SREBP‐1 and RNA polymerase II to HCFC1 and FLNA. From the results of this work, we infer that SREBP‐1 may be involved in processes other than lipid metabolism.


Genome Research | 2007

The landscape of histone modifications across 1% of the human genome in five human cell lines

Christoph M. Koch; Robert Andrews; Paul Flicek; Shane C. Dillon; Ulaş Karaöz; Gayle K. Clelland; Sarah Wilcox; David Beare; Joanna C. Fowler; Phillippe Couttet; Keith D. James; Gregory C. Lefebvre; Alexander W. Bruce; Oliver M. Dovey; Peter Ellis; Pawandeep Dhami; Cordelia Langford; Zhiping Weng; Ewan Birney; Nigel P. Carter; David Vetrie; Ian Dunham


Genome Research | 2008

Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets

David M. S. Johnson; Wei Li; D. Benjamin Gordon; Arindam Bhattacharjee; Bo Curry; Jayati Ghosh; Leonardo Brizuela; Jason S. Carroll; Myles Brown; Paul Flicek; Christoph M. Koch; Ian Dunham; Mark Bieda; Xiaoqin Xu; Peggy J. Farnham; Philipp Kapranov; David A. Nix; Thomas R. Gingeras; Xinmin Zhang; H. Holster; Nan Jiang; Roland D. Green; Jun S. Song; Scott McCuine; Elizabeth Anton; Loan Nguyen; Nathan D. Trinklein; Zhen Ye; Keith A. Ching; David Hawkins


Genome Research | 2007

Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes

Alvaro Rada-Iglesias; Stefan Enroth; Adam Ameur; Christoph M. Koch; Gayle K. Clelland; Patricia Respuela-Alonso; Sarah Wilcox; Oliver M. Dovey; Peter Ellis; Cordelia Langford; Ian Dunham; Jan Komorowski; Claes Wadelius


Human Molecular Genetics | 2005

Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays

Alvaro Rada-Iglesias; Ola Wallerman; Christoph M. Koch; Adam Ameur; Stefan Enroth; Gayle K. Clelland; Kenneth Wester; Sarah Wilcox; Oliver M. Dovey; Peter Ellis; Vicki Wraight; Keith D. James; Robert Andrews; Cordelia Langford; Pawandeep Dhami; Nigel P. Carter; David Vetrie; Fredrik Pontén; Jan Komorowski; Ian Dunham; Claes Wadelius


Blood | 2007

Tissue-specific histone modification and transcription factor binding in alpha globin gene expression.

Marco Gobbi; Eduardo Anguita; Jim R. Hughes; Jacqueline Sloane-Stanley; Jacqueline A. Sharpe; Christoph M. Koch; Ian Dunham; Richard J. Gibbons; William G. Wood; Douglas R. Higgs

Collaboration


Dive into the Christoph M. Koch's collaboration.

Top Co-Authors

Avatar

Ian Dunham

European Bioinformatics Institute

View shared research outputs
Top Co-Authors

Avatar

Cordelia Langford

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

David Vetrie

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Gayle K. Clelland

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Pawandeep Dhami

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Peter Ellis

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Robert Andrews

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Shane C. Dillon

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Keith D. James

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Oliver M. Dovey

Wellcome Trust Sanger Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge